1. HIV-1 exploits LBPA-dependent intraepithelial trafficking for productive infection of human intestinal mucosa.
- Author
-
Rader, Anusca G., Cloherty, Alexandra P. M., Patel, Kharishma S., Almandawi, Dima D. A., Pajkrt, Dasja, Wolthers, Katja C., Sridhar, Adithya, van Piggelen, Sterre, Baaij, Liselotte E., Schreurs, Renée R. C. E., and Ribeiro, Carla M. S.
- Subjects
- *
INTESTINAL mucosa , *DRUG discovery , *VIRUS diseases , *INTESTINAL infections , *CELL compartmentation - Abstract
The gastrointestinal tract is a prominent portal of entry for HIV-1 during sexual or perinatal transmission, as well as a major site of HIV-1 persistence and replication. Elucidation of underlying mechanisms of intestinal HIV-1 infection are thus needed for the advancement of HIV-1 curative therapies. Here, we present a human 2D intestinal immuno-organoid system to model HIV-1 disease that recapitulates tissue compartmentalization and epithelial-immune cellular interactions. Our data demonstrate that apical exposure of intestinal epithelium to HIV-1 results in viral internalization, with subsequent basolateral shedding of replication-competent viruses, in a manner that is impervious to antiretroviral treatment. Incorporation of subepithelial dendritic cells resulted in HIV-1 luminal sampling and amplification of residual viral replication of lab-adapted and transmitted-founder (T/F) HIV-1 variants. Markedly, intraepithelial viral capture ensued an altered distribution of specialized endosomal pathways alongside durable sequestration of infectious HIV-1 within lysobisphosphatidic acid (LPBA)-rich vesicles. Therapeutic neutralization of LBPA-dependent trafficking limited productive HIV-1 infection, and thereby demonstrated the pivotal role of intraepithelial multivesicular endosomes as niches for virulent HIV-1 within the intestinal mucosa. Our study showcases the application of primary human 2D immune-competent organoid cultures in uncovering mechanisms of intestinal HIV-1 disease as well as a platform for preclinical antiviral drug discovery. Author summary: The human intestine forms an important roadblock against viruses, including HIV-1. Nevertheless, upon sexual contact HIV-1 is able to penetrate the intestinal barrier and infect cells of our immune system within the intestine, resulting in HIV-1 infection of the human body. Little is still known about how HIV-1 can outsmart this protective intestinal barrier and establish an infection. Here, we reconstructed the human intestine outside the human body and developed a novel mini-gut model containing relevant immune cells that allowed us to track the HIV-1's footsteps throughout the intestine in the laboratory. Using advanced imaging technology, we have uncovered that HIV-1 specifically hijacks vesicles studded with the particular molecule (LBPA) that are produced inside of the intestinal barrier cells to subsequently spread infection to adjacent intestinal cells. Importantly, blockade of these LBPA-enriched vesicles with an antibody suppressed intestinal HIV-1 infection. Our study substantiates the use of upgraded human gut models to deepen our knowledge about human viral diseases as well as underscores the development of therapies targeting LBPA for superior control of intestinal HIV-1 disease in people living with HIV-1. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF